These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8466133)

  • 1. Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis.
    Brindle RJ; Nunn PP; Githui W; Allen BW; Gathua S; Waiyaki P
    Am Rev Respir Dis; 1993 Apr; 147(4):958-61. PubMed ID: 8466133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis.
    Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Mugerwa RD; Ellner JJ; Eisenach KD
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):528-36. PubMed ID: 10864183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia.
    Elliott AM; Namaambo K; Allen BW; Luo N; Hayes RJ; Pobee JO; McAdam KP
    Tuber Lung Dis; 1993 Jun; 74(3):191-4. PubMed ID: 8369514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
    Kennedy N; Fox R; Kisyombe GM; Saruni AO; Uiso LO; Ramsay AR; Ngowi FI; Gillespie SH
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1547-51. PubMed ID: 8256898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection.
    Jones BE; Otaya M; Antoniskis D; Sian S; Wang F; Mercado A; Davidson PT; Barnes PF
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1499-502. PubMed ID: 7952606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
    Jindani A; Doré CJ; Mitchison DA
    Am J Respir Crit Care Med; 2003 May; 167(10):1348-54. PubMed ID: 12519740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
    Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence.
    Samb B; Sow PS; Kony S; Maynart-Badiane M; Diouf G; Cissokho S; Bâ D; Sané M; Klotz F; Faye-Niang MA; Mboup S; Ndoye I; Delaporte E; Hane AA; Samb A; Coulaud JP; Coll-Seck AM; Larouzé B; Murray JF
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):330-6. PubMed ID: 10206504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results.
    Githui W; Nunn P; Juma E; Karimi F; Brindle R; Kamunyi R; Gathua S; Gicheha C; Morris J; Omwega M
    Tuber Lung Dis; 1992 Aug; 73(4):203-9. PubMed ID: 1477386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of mycobacterial species in clinically diagnosed cases of pulmonary tuberculosis and their HIV status.
    Patwardhan NS; Bansal MP; Pradhan J
    Indian J Pathol Microbiol; 1997 Jul; 40(3):365-7. PubMed ID: 9354009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group.
    Lancet; 1999 Jul; 354(9173):116-9. PubMed ID: 10408487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative bacillary response to treatment in Mycobacterium tuberculosis infected and M. africanum infected adults with pulmonary tuberculosis.
    Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Rüsch-Gerdes S; Mugerwa RD; Ellner JJ; Eisenach KD
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):579-82. PubMed ID: 11409588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.
    Dutt AK; Moers D; Stead WW
    Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1232-5. PubMed ID: 2111106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months.
    Perriëns JH; St Louis ME; Mukadi YB; Brown C; Prignot J; Pouthier F; Portaels F; Willame JC; Mandala JK; Kaboto M
    N Engl J Med; 1995 Mar; 332(12):779-84. PubMed ID: 7862181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two versus three smears in identifying culture-positive tuberculosis patients in a rural African setting with high HIV prevalence.
    Crampin AC; Floyd S; Mwaungulu F; Black G; Ndhlovu R; Mwaiyeghele E; Glynn JR; Warndorff DK; Fine PE
    Int J Tuberc Lung Dis; 2001 Nov; 5(11):994-9. PubMed ID: 11716350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.